Infectopyoderm (Mupirocin)

Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, preventing the incorporation of isoleucine into bacterial proteins. This blocks protein synthesis, leading to growth arrest and, at higher concentrations, bacterial cell death, primarily against Gram‑positive organisms like Staphylococcus aureus and Streptococcus pyogenes.

The specific dose and frequency of Infectopyoderm are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and other clinical factors. Patients should follow the prescriber’s instructions and not alter the regimen on their own.

Limited clinical data are available on the use of topical mupirocin during pregnancy or lactation. Healthcare providers should weigh the potential benefits against any possible risks and consider alternative treatments if appropriate. Pregnant or nursing patients should discuss use with their physician.

To place an order, submit an enquiry on the Infectopyoderm product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Infectopyoderm (mupirocin) offers a broad spectrum against Gram‑positive bacteria and has a low propensity for systemic absorption, making it suitable for localized infections. Compared with alternatives such as fusidic acid, mupirocin often provides faster bacterial eradication and is less associated with resistance in certain settings.

Store Infectopyoderm at room temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain stability.

Infectopyoderm is applied topically to clean, dry skin. A thin layer is spread over the affected area, usually two to three times daily, or as directed by the prescriber. Hands should be washed before and after application, and the treated area should be covered only if advised.

Serious adverse reactions, although rare, include severe contact dermatitis, anaphylaxis and Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, widespread rash, blistering or mucosal involvement after using the product.

Infectopyoderm should be avoided in individuals with a known hypersensitivity to mupirocin or any component of the formulation. It is also not intended for ocular use, and patients with extensive skin damage or those requiring systemic antibiotic therapy should be evaluated by a clinician for alternative treatment.